CVD 908, CVD 908-htrA, and CVD 909 Live Oral Typhoid Vaccines: A Logical Progression
Open Access
- 15 July 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (Supplement) , S20-S23
- https://doi.org/10.1086/518135
Abstract
Typhoid fever remains an important public health problem in many parts of the world. Despite the availability of oral Ty21a (Vivotif; Berna Biotech)Keywords
This publication has 28 references indexed in Scilit:
- The Novel Oral Typhoid Vaccine M01ZH09 Is Well Tolerated and Highly Immunogenic in 2 Vaccine PresentationsThe Journal of Infectious Diseases, 2005
- phoP/phoQ-Deleted Salmonella typhi (Ty800) Is a Safe and Immunogenic Single Dose Typhoid Fever Vaccine in VolunteersThe Journal of Infectious Diseases, 1996
- Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectorsJournal of Biotechnology, 1996
- Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strainVaccine, 1992
- Construction of genetically defined double aro mutants of Salmonella typhiVaccine, 1991
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981
- RUBELLA VIRAEMIA AND ANTIBODY RESPONSES AFTER RUBELLA VACCINATION AND REIMMUNISATIONThe Lancet, 1981
- Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid VaccineThe Journal of Infectious Diseases, 1975
- FREE AND BOUND VIRUS IN SERUM AFTER ADMINISTRATION OF ORAL POLIOVIRUS VACCINE1American Journal of Epidemiology, 1966
- VIREMIA IN INFANTS VACCINATED WITH ORAL POLIOVIRUS VACCINE (SABIN)1*American Journal of Epidemiology, 1964